(firstQuint)Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet).

 This study aims to compare the absorption and disposition kinetics of two products containing rosuvastatin under fasting conditions.

 These products are: Rosuvastatin/ Verisfield 20 mg film-coated tablets, a Test product manufactured by HELP S.

A.

, Greece and Crestor cent / AstraZeneca 20 mg film-coated tablets, a Reference product manufactured by AstraZeneca, UK.

 The bioequivalence of a single 20 mg dose of both products will be assessed by comparing the pharmacokinetic parameters derived from the plasma concentration-time profiles for rosuvastatin.

.

 Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)@highlight

The purpose of this study is to determine the bioequivalence of Rosuvastatin/ Verisfield 20 mg film-coated tablets and Crestor cent / AstraZeneca 20 mg film-coated tablets.

